The phrase "a prominent difference in" is correct and usable in written English.
It can be used when discussing noticeable or significant distinctions between two or more subjects or items.
Example: "There is a prominent difference in the quality of the two products, which affects consumer choice."
Alternatives: "a significant difference in" or "a marked difference in".
A prominent difference in the active site architecture of VCPO and VBPO is the presence of a second histidine in VBPO, a residue substituted by a phenylalanine in VCPO.
A prominent difference in the global rate of exchange of the amidic protons of scPCNA versus hPCNA can be appreciated by looking at the reference 1H-15N correlation spectra (in buffered H2O) and those recorded immediately (∼1 hr) after D2O exchange (Fig. 3).
Moreover a prominent difference in the biliary excretion rate of zone 1 and zone 3 hepatocytes was found for taurocholate.
A prominent difference in the P6a structure is noted among introns possessing L5b GNRA tetraloops compared to those with penta- or hexaloops.
However, there was still a prominent difference in PaO2 between the baseline level and the level at 10 min after suctioning (70.1 ± 18.7 mmHg versus 89.6 ± 15.1 mmHg, P < 0.05).
No obvious phenotypic differences in growth habit, flower development or embryo morphology were detected between Fe-1 and Col-0 to suggest such a prominent difference in response to loss of ZLL function.
As such, a prominent difference was noted in the proportion of infants with grades III and IV IVH when data were compared: 4% of Amin et al.'s total sample vs. 25% of Polycarpou et al.'s total sample [ 30, 31].
In both species, MECP2 was undetectable in rods, in a prominent difference to neuroretinal cells and cone photoreceptors where it produced a clear signal.
Obviously, both factors will probably result in a lower sensitivity for medium sized adenomas and a less prominent difference in the detection of adenomas ≥ 10 mm compared to the studies of Graser [ 26] and Pickhardt [ 30, 31].
Since the NO-donor promoted a more prominent difference in viability between the RKO cells with endogenous TR1 compared to the cells with TR1 knocked-down, additional evaluation of cellular redox status were performed to evaluate the mechanism of the NO-mediated enhanced cytotoxicity.
In particular, a prominent difference existed between care managers and visiting physicians, who were the top 2 home care providers that family caregivers would consult when uncertain about using physical restraints themselves.
